[2] 王友春,马建党,韩宏锋,等.胃癌化疗前后循环血浆VEGF、1L-8变化的临床意义[J].胃肠病学和肝病学杂志,2008,17 (3):226-227.
[2] Ajani,J A.Evolving chemotlierapy for advanced gastric cancer[J].Oncologist, 2005,10 (3):4958.
[3] 倪效,燕敏. VEGF'受体功能研究进展[J].生命科学,2008,20 (1):120-124.
[4] 石海,许建明.COX-2、VEGF在胃癌中的表达及其预后意义[J].中国癌症杂志,2003,13 (6):518-522.
[5] Liu LY, Han YC, Wu SH, et al. Expression of connective tissuegrowth factor in tumor is an independent predictor of poor prognosisin patients with gastric cancer[J].World,J Gastroentero1,2008,14(13):21102114.
[6] 何家才,阮敏,王元银,等.血管内皮生长因子和微血管密度在口腔鳞癌中的表达[J].安徽医科大学学报,2006,41 (1):41-43.
[7] 薛洪燕,陈丽荣.子宫颈鳞状细胞癌VEGF-C及其受体、vEGFR_3的表达及其临床意义[J].实用肿瘤杂志,2008,23 (1):24-27.
[8] 彭莉,朱传金,刘玉红,等.血清CL,A. CA19-9. CA242联检在大肠癌诊断及随访中的临床应用[J].放射免疫学杂志,2006,19 (3):239241.
[1] Gondon NS, Hadlow G, Knight E et al. Transurethral resection of the prostate:still the gold standard[J].Aust N Z Surg, 1997 67 (6):354357.
[2] Alivizatos G, Skolarikos A. Greenlight laser in benign prostatic hyperplasia:turning green into gold[J].Curr Opin Lro1,2008,18 (1):4649.
[3] Van CB, Srirangam SJ, Van P11. High-Performance system Greenlight laser: indications and outcomes[J].Curr Opin Lrol, 2009,19(1):33-37.
[4] Malek RS, Nahen K. Laser treatment of obstructive BPH: Problems and progress[J].Contemp Crol, 2004, 16 (5):37- 43.
[13]
[5] Barber NJ, Muir GH. High-Power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate[J].Curr Opin Cro1,2004,14(1):21-25.
[6] Sohn JH, Choi YS, Kim SJ, et al. L,ffectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants[J].Korean J Croh 2011, 52 (3):178183.
[7] 张琦,王慕文,赵勇.术前口服非那雄胺及留置导尿管对光选 择性前列腺汽化术有无影响的研究[J].泌尿外科杂志:电子 版,2011,3 (1):3134.
[17]
[8] 熊玮,冉清,窦科,等.经尿道选择性绿激光汽化术治疗大体 积良性前列腺增生症[J].华西医学,2010, 25 (9): 1615- 1617.
[9] 梁伟东,白亮,钟羽翔,等.经尿道前列腺电切术(TURP)患者 PS A变化的临床研究[J].遵义医学院学报,2008, 31 (2) 132133.
[10] 中长发,刘辉,金讯波,等.经尿道选择性绿激光前列腺汽化 术治疗巨大前列腺增生症[J].山东大学学报:医学版,2008, 64 (12):12071208.